AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.6592
-0.0088 (-1.32%)
At close: Jun 22, 2026, 4:00 PM EDT
0.6417
-0.0175 (-2.65%)
Pre-market: Jun 23, 2026, 6:21 AM EDT
AEON Biopharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
8
Market Cap
17.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAEON News
- 19 days ago - AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society - GlobeNewsWire
- 5 weeks ago - AEON Biopharma Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - AEON Biopharma Earnings release: Q1 2026 - Filings
- 5 weeks ago - AEON Biopharma Quarterly report: Q1 2026 - Filings
- 5 weeks ago - Aeon Biopharma management to meet virtually with Lake Street - TheFly
- 5 weeks ago - AEON Biopharma Slides: Corporate presentation - Filings
- 7 weeks ago - AEON Biopharma Proxy statement: Proxy filing - Filings
- 7 weeks ago - AEON Biopharma Proxy statement: Proxy filing - Filings